|
 |
Welcome to Drug Design 2012
Drug Design 2012 will address the latest developments in computational and experimental approaches to ligand- and structure-based drug design. The conference is aimed at bringing together biologists, chemists and computational scientists from academia and industry to discuss the latest developments and breakthroughs in cutting-edge in silico and experimental drug design approaches. The conference invites podium and poster proposals in the following general areas of drug design:-
- Molecular modelling and simulation
- Novel drugable targets: Identification and selection
- Fragment binding and selectivity
- Ligand design and identification
- Target-ligand interaction (including proteins and nucleic acids)
- In silico and experimental screening technologies
Who Should Attend
- Academia: Lab heads, postdoctoral researchers, graduate research students
- Industry: Team leaders, junior researchers, research managers and decision makers
|
|
|
